Foundation Medicine
Foundation Medicine, Inc. is an American company based in Cambridge, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.
| Company type | Subsidiary |
|---|---|
| Headquarters | , United States |
Key people | Brian Alexander (CEO) |
| Products | FoundationOne CDx FoundationOne Liquid FoundationOne Heme Foundation Insights FoundationSmartTrials |
| Revenue | $152.9 million (2017) |
| Owners | Roche |
| Website | foundationmedicine |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.